🔗 Permalink

Inventor profile of:

Jun Yang

City:

Ballwin, Missouri

Country:

United States

Published Applications:

Last publication date:

2026-02-19

Top Assignees for applications by Jun Yang

The entities that hold a legal rights for patent applications filed by inventor Yang Jun:

MALLINCKRODT LLC 3 Hazelwood, MO United States
Humanwell Pharmaceutical US 2 Ballwin, MO United States
HUMANWELL PHARMACEUTICAL US, Inc. 2 Ballwin, MO United States
Yichang Humanwell Pharmaceuticals Co. Ltd. 2 Yichang, China
YICHANG HUMANWELL PHARMACEUTICAL CO., LTD. 1 Hubei, MO China

Recent patent applications by Yang Jun

Jun Yang from Ballwin, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-19

US20260049061A1

Chemistry; metallurgy

SMALL MOLECULES AS KCNQ2/3 (KV7.2/3) CHANNEL ACTIVATORS AND THEIR MEDICAL USE THEREOF

#2 | 2026-02-05

US20260034098A1

Human necessities

BRIDGED TRICYCLIC GABA DERIVATIVES AS CALCIUM CHANNEL MODULATORS, METHODS OF MAKING AND METHODS OF USING THEREOF

#3 | 2026-01-15

US20260015365A1

Chemistry; metallurgy

PRODRUGS OF SOMATOSTATIN RECEPTORS SUBTYPE 4 (SSTR4) AGONISTS AND THEIR APPLICATIONS

#4 | 2025-08-14

US20250255878A1

Human necessities

SMALL MOLECULE INHIBITORS OF NAV1.8 SODIUM CHANNELS FOR PAIN RELIEF

#5 | 2025-03-20

US20250092091A1

Chemistry; metallurgy

KAPPA OPIOID RECEPTOR PEPTIDE AMIDE LIGANDS

#6 | 2024-12-05

US20240400554A1

Chemistry; metallurgy

MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS FOR THE TREATMENT OF PAIN AND RELATED MEDICAL DISORDERS

#7 | 2024-05-30

US20240174693A1

Chemistry; metallurgy

SOMATOSTATIN RECEPTOR SUBTYPE 4 (SSTR4) AGONISTS AND THEIR APPLICATIONS

#8 | 2023-08-17

US20230255956A1

Human necessities

PHARMACEUTICAL FORMULATIONS CONTAINING NALBUPHINE

#9 | 2022-11-10

US20220354923A1

Human necessities

PEPTIDES FOR TREATMENT OF MEDICAL DISORDERS

#10 | 2022-03-24

US20220089605A1

Chemistry; metallurgy

NOVEL MORPHINANS USEFUL FOR TREATING MEDICAL DISORDERS

#11 | 2022-02-17

US20220047566A1

Human necessities

LONG ACTING IN-SITU FORMING/GELLING COMPOSITIONS

#12 | 2021-12-30

US20210403505A1

Chemistry; metallurgy

Peptides for treatment of medical disorders

#13 | 2021-02-11

US20210040150A1

Chemistry; metallurgy

Kappa opioid receptor peptide amide ligands

#14 | 2020-10-01

US20200308185A1

Chemistry; metallurgy

Morphinans useful for treating medical disorders

#15 | 2019-06-13

US20190175505A1

Human necessities

COMBINATIONAL LIPOSOME COMPOSITIONS FOR CANCER THERAPY

#16 | 2019-02-21

US20190054024A1

Human necessities

Solid Dosage Forms

#17 | 2018-01-18

US20180015039A1

Human necessities

Combinational liposome compositions for cancer therapy

#18 | 2016-11-24

US20160338958A1

Human necessities

Combinational liposome compositions for cancer therapy

#19 | 2015-10-29

US20150306225A1

Human necessities

Compositions for Delivering Drugs with Low Water Solubility

#20 | 2013-05-09

US20130115273A1

Human necessities

Combinational liposome compositions for cancer therapy

InventorID:

234290 ⎘